Filter
3100
Filtered Results: 3100
Text search:
adverse
health
outcomes
Featured
Recommendations
330
New Publications
798
Language
Document type
No document type
1725
Studies & Reports
513
Guidelines
501
Manuals
151
Strategic & Response Plan
99
Fact sheets
44
Training Material
42
Situation Updates
14
Resource Platforms
6
Infographics
2
Brochures
1
App
1
Online Courses
1
Countries / Regions
India
147
Global
130
Kenya
71
Western and Central Europe
71
South Africa
69
Ethiopia
66
Nigeria
53
Nepal
48
Uganda
41
Africa
40
Sierra Leone
39
Latin America and the Carribbean
36
Zambia
36
Tanzania
35
Malawi
34
Bangladesh
34
Ghana
33
Liberia
32
Philippines
31
Myanmar / Burma
30
Rwanda
25
Eastern Europe
24
South–East Asia Region
23
Cambodia
21
Namibia
21
Ukraine
18
Brazil
18
Zimbabwe
15
East and Southern Africa
15
Asia
14
Syria
13
Indonesia
13
Lesotho
12
Guinea
12
USA
12
Colombia
10
Mozambique
10
Eastern Europe and Central Asia
10
Botswana
10
West and Central Africa
9
Middle East and North Africa
9
Senegal
8
Thailand
7
Burkina Faso
7
Germany
7
Western Pacific Region
7
South Sudan
7
Eswatini/ Swaziland
7
Pakistan
7
Chile
6
Haiti
6
Congo, Democratic Republic of
6
Moldova
6
Russia
6
Sudan
6
Afghanistan
5
Venezuela
5
Jordan
5
Lebanon
5
Cameroon
4
Laos
4
Paraguay
4
United Kingdom
4
Argentina
4
Ecuador
4
Timor Leste/ East Timor
3
Benin
3
Egypt
3
Palestine
3
Somalia
3
Tajikistan
2
China
2
Singapore
2
Niger
2
Bolivia
2
Vietnam
2
Papua New Guinea
2
Yemen
2
Romania
2
Georgia
2
Central African Republic
2
Angola
2
Bhutan
2
Madagascar
2
North Macedonia
1
El Salvador
1
Australia
1
Gambia
1
Kazakhstan
1
Iran
1
Albania
1
Canada
1
Kyrgyzstan
1
Burundi
1
Peru
1
Bulgaria
1
Guinea-Bissau
1
Lithuania
1
Ireland
1
North America
1
Japan
1
Mauritius
1
Sri Lanka
1
Poland
1
Honduras
1
Mali
1
Libya
1
Iraq
1
Solomon Islands
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
991
Clinical Guidelines
365
Public Health
195
Women & Child Health
176
Key Resources
133
Capacity Building
46
Pharmacy & Technologies
29
Toolboxes
Mental Health
339
TB
235
COVID-19
225
HIV
221
Planetary Health
161
NCDs
89
Caregiver
87
Pharmacy
87
AMR
80
NTDs
72
Rapid Response
70
Ebola
58
Global Health Education
58
Disability
54
Conflict
50
Refugee
49
Zika
33
Natural Hazards
25
Health Financing Toolbox
19
Cholera
16
Polio
16
Specific Hazards
15
Social Ethics
6
Typhoon
1
These guidelines provide evidence-based guidance on the use of peripartum antiviral prophylaxis in HBsAg-positive pregnant women for the prevention of mother-to-child transmission of HBV.
6 July 2021. Three new nucleic acid amplification test (NAAT) classes are endorsed by WHO and included.
The latest operational handbook includes the new classes recommended by WHO. It aims at facilitating the implementation of the WHO recommendations by the Member States, technical partners, and ot...
Just about everyone has experienced the joy that a healthy newborn child brings to parents, families and communities. But the arrival of a newborn who is small or sick often results in immediate worry and sadness. When the infant is at high risk of death or disability, these concerns can be a tremen...
Sepsis contributes significantly to preventable mortality and is the final common pathway to death for severe infectious diseases; it can also arise as a complication of injuries and non-communicable diseases.
General practitioners and pediatricians must know the signs and
symptoms of possible pediatric cancer.
Sepsis remains a leading cause of mortality and morbidity, especially during the first five days of life and in low and middle-income countries (LMIC) [1]. Hospital infection also remains a major cause of mortality in children despite progress encountered in the last decades.
Results of rapid assessment
The COVID-19 pandemic has disrupted or halted critical mental health services in 93% of countries worldwide while the demand for mental health is increasing, according to a new WHO survey. The survey of 130 countries provides the first global data showing the devastating...
As of 31 October 2020 This is the tenth edition of this summary of rapid systematic reviews, which includes the results of a rapid systematic review of currently available literature. More than 200 therapeutic options or their combinations are being investigated in more than 1,700 clinical trials. I...
Despite being a curable and preventable disease, tuberculosis (TB) remains as one of the major challenges for health systems, globally. Every year, TB affects more than 10 million people and kills more than 1.4 million people. WHO’s Digital Health for the End TB Strategy – an Agenda for Action o...
Antimalarial drug resistance has emerged as a threat to global malaria control efforts, particularly in the Greater Mekong subregion. Drawing on data collected through more than 1000 therapeutic efficacy studies as well as molecular marker studies of Plasmodium falciparum drug resistance, the Report...
The conduct of COVID-19 vaccine trials in the context of a candidate vaccine being issued with Emergency Use Designation raises challenging ethical questions, including in relation to the use of placebo controls and unblinding of trial participants in current and future COVID-19 vaccine trials. This...
Guidelines on the management of chronic pain in children, developing and implementing national and local policies for pain management and protocols in children, implementing national and local regulations for pain management in children, pain management and protocols
These WHO interim recommendations on the use of the Astra Zeneca – Oxford University AZD1222 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenc...
his Inter Action Review report for the COVID-19 outbreak in Mauritius documents and assesses the country’s capacity to respond to the outbreak and identifies the best practices, strengths, gaps and challenges of the national response. Areas requiring improvements or sustained actions have been ide...
1 February 2021 to 31 January 2022
UNAIDS and the World Health Organization have published this updated guidance on ethical considerations in HIV prevention trials. The new guidance is the result of a year-long process that saw more than 80 experts and members of the public give inputs and is published 21 years after the first editio...
